BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 19141684)

  • 41. A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-gamma activity.
    Schupp M; Curtin JC; Kim RJ; Billin AN; Lazar MA
    Mol Pharmacol; 2007 May; 71(5):1251-7. PubMed ID: 17290005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation.
    Bouaboula M; Hilairet S; Marchand J; Fajas L; Le Fur G; Casellas P
    Eur J Pharmacol; 2005 Jul; 517(3):174-81. PubMed ID: 15987634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scoparone inhibits adipocyte differentiation through down-regulation of peroxisome proliferators-activated receptor γ in 3T3-L1 preadipocytes.
    Noh JR; Kim YH; Hwang JH; Gang GT; Yeo SH; Kim KS; Oh WK; Ly SY; Lee IK; Lee CH
    Food Chem; 2013 Nov; 141(2):723-30. PubMed ID: 23790840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chebulagic acid from Terminalia chebula enhances insulin mediated glucose uptake in 3T3-L1 adipocytes via PPARγ signaling pathway.
    Shyni GL; Kavitha S; Indu S; Arya AD; Anusree SS; Vineetha VP; Vandana S; Sundaresan A; Raghu KG
    Biofactors; 2014; 40(6):646-57. PubMed ID: 25529897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A high-capacity assay for PPARgamma ligand regulation of endogenous aP2 expression in 3T3-L1 cells.
    Thompson GM; Trainor D; Biswas C; LaCerte C; Berger JP; Kelly LJ
    Anal Biochem; 2004 Jul; 330(1):21-8. PubMed ID: 15183757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The DLK gene is a transcriptional target of PPARγ.
    Couture JP; Blouin R
    Biochem J; 2011 Aug; 438(1):93-101. PubMed ID: 21585338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of fat-specific protein 27 in the adipocyte lineage suggests a dual role for FSP27 in adipocyte metabolism and cell death.
    Kim JY; Liu K; Zhou S; Tillison K; Wu Y; Smas CM
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E654-67. PubMed ID: 18198355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C; Arribas M; Benito M; Valverde AM
    Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation.
    Sentinelli F; Filippi E; Cavallo MG; Romeo S; Fanelli M; Baroni MG
    J Endocrinol; 2006 Feb; 188(2):271-85. PubMed ID: 16461553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adipocyte-specific expression of murine resistin is mediated by synergism between peroxisome proliferator-activated receptor gamma and CCAAT/enhancer-binding proteins.
    Tomaru T; Steger DJ; Lefterova MI; Schupp M; Lazar MA
    J Biol Chem; 2009 Mar; 284(10):6116-25. PubMed ID: 19126543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcription suppression of peroxisome proliferator-activated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/ enhancer-binding protein delta during the early stage of adipocyte differentiation.
    Kudo M; Sugawara A; Uruno A; Takeuchi K; Ito S
    Endocrinology; 2004 Nov; 145(11):4948-56. PubMed ID: 15284209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic profile and adipogenic role of growth differentiation factor 5 (GDF5) in the differentiation of 3T3-L1 preadipocytes.
    Pei Z; Yang Y; Kiess W; Sun C; Luo F
    Arch Biochem Biophys; 2014 Oct; 560():27-35. PubMed ID: 25078108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bisindoylmaleimide I suppresses adipocyte differentiation through stabilization of intracellular beta-catenin protein.
    Cho M; Park S; Gwak J; Kim DE; Yea SS; Shin JG; Oh S
    Biochem Biophys Res Commun; 2008 Feb; 367(1):195-200. PubMed ID: 18174026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lupenone isolated from Adenophora triphylla var. japonica extract inhibits adipogenic differentiation through the downregulation of PPARγ in 3T3-L1 cells.
    Ahn EK; Oh JS
    Phytother Res; 2013 May; 27(5):761-6. PubMed ID: 22848028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes.
    Rosenbaum SE; Greenberg AS
    Mol Endocrinol; 1998 Aug; 12(8):1150-60. PubMed ID: 9717841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PPARγ agonist through the terminal differentiation phase is essential for adipogenic differentiation of fetal ovine preadipocytes.
    Pu Y; Veiga-Lopez A
    Cell Mol Biol Lett; 2017; 22():6. PubMed ID: 28536637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Ganoderma applanatum mycelium extract on the inhibition of adipogenesis in 3T3-L1 adipocytes.
    Kim JE; Park SJ; Yu MH; Lee SP
    J Med Food; 2014 Oct; 17(10):1086-94. PubMed ID: 25140758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipolytic and antiadipogenic effects of (3,3-dimethylallyl) halfordinol on 3T3-L1 adipocytes and high fat and fructose diet induced obese C57/BL6J mice.
    Saravanan M; Pandikumar P; Saravanan S; Toppo E; Pazhanivel N; Ignacimuthu S
    Eur J Pharmacol; 2014 Oct; 740():714-21. PubMed ID: 24952133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PPARγ agonists induce adipocyte differentiation by modulating the expression of Lipin-1, which acts as a PPARγ phosphatase.
    Kim J; Lee YJ; Kim JM; Lee SY; Bae MA; Ahn JH; Han DC; Kwon BM
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):57-66. PubMed ID: 27780754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altering PPARgamma ligand selectivity impairs adipogenesis by thiazolidinediones but not hormonal inducers.
    Samarasinghe SP; Sutanto MM; Danos AM; Johnson DN; Brady MJ; Cohen RN
    Obesity (Silver Spring); 2009 May; 17(5):965-72. PubMed ID: 19165156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.